Reports
Sale
North America Clinical Trials Market Size, Growth, Forecast: By Service Type: Laboratory Service, Bioanalytical Testing Services, Decentralized Clinical Trial Services, Patient Recruitment Services, Site Identification Services, Others; By Phase; By Therapeutic Area; By Application; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032
North America Clinical Trials Market Outlook
The North America clinical trials market size was valued at USD 35.31 billion in 2023. The market is further projected to grow at a CAGR of 6.0% between 2024 and 2032, reaching a value of USD 60.16 billion by 2032.
Key Takeaways
- The Canadian pharmaceutical sector leads in clinical trial initiation in the country, especially in trials for drugs for rare diseases and oncology products.
- In 2022, the United States accounted for 18.4% of the global clinical trial activity.
- In 2021, Canada accounted for a 3.8% share of the global clinical trials activity.
According to the North America clinical trials market analysis, clinical trials are a crucial testing ground for potential drugs and devices. The advancing technological landscape in the healthcare sector has enhanced the way life science companies conduct clinical trials. Technologies, such as artificial intelligence, decentralised clinical trials, and wearable devices help companies conducting clinical trials overcome common challenges of the market, such as poor study design, ineffective site selection, and participant dropout.
A strong regulatory framework in the field of clinical trials is also strengthening the North America clinical trials market development. For instance, Health Canada, the Federal department helping Canadians maintain and improve their health, is working on modernising the Canadian clinical trials’ regulatory framework. It proposes the establishment of a single authorisation of a trial involving multiple health products, the use of a risk-based approach for regulating clinical trials, and the approval of decentralised/hybrid trials to increase diversity and inclusion. In the United States, the Food and Drug Administration (FDA) sets rigorous standards for clinical trial design, collecting and analysing data, and reviewing all applications for new drug approvals.
Industry-sponsored trials are widely popular in North America. In 2022, these trials accounted for 63.9% share of all the clinical trials in the United States. Oncology was the leading therapeutic area for industry-sponsored clinical trials with a 37.0% share in the United States in 2022.
Market Segmentation
North America Clinical Trials Market Report and Forecast 2024-2032 offers a detailed analysis of the market based on the following segments.
Market Breakup by Service Type
- Laboratory Service
- Bioanalytical Testing Services
- Cell-Based Assays
- Virology Testing
- Serology, Immunogenicity, and Neutralizing Antibodies
- PK/PD Testing
- Method Development, Optimisation, and Validation
- Biomarker Testing
- Others
- Decentralized Clinical Trial Services
- Patient Recruitment Services
- Site Identification Services
- Analytical Testing Services
- Supply and Logistics Services
- Protocol Designing Services
- Data Management Services
- Medical Device Testing Services
- Others
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Therapeutic Area
- Oncology
- Infectious Diseases
- Neurology
- Metabolic Disorders
- Immunology
- Cardiology
- Genetic Diseases
- Women’s Health
- Others
Market Breakup by Application
- Small Molecules
- Monoclonal Antibodies
- Vaccines
- Cell and Gene Therapy
- Others
Market Breakup by Country
- United States of America
- Canada
Competitive Landscape
The key players in the clinical trials market in North America are conducting trials in accordance with the stringent regulatory framework in the region.
- IQVIA Inc
- Laboratory Corporation of America Holdings
- Syneos Health
- Charles River Laboratories
- Thermo Fisher Scientific Inc
- Parexel International (MA) Corporation
- Medpace, Inc.
- ACM Global Laboratories
- Frontage Labs
- Dropoff, Inc.
- Others
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Service Type |
|
| Breakup by Phase |
|
| Breakup by Therapeutic Area |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Opportunities and Challenges in the Market
8 Global Clinical Trials Market Overview
8.1 Key Industry Highlights
8.2 Global Clinical Trials Historical Market (2017-2023)
8.3 Global Clinical Trials Market Forecast (2024-2032)
8.4 Global Clinical Trials Market Share by Region
8.4.1 North America
8.4.2 Europe
8.4.3 Asia Pacific
8.4.4 Latin America
8.4.5 Middle East and Africa
9 North America Clinical Trials Market Overview
9.1 Key Industry Highlights
9.2 North America Clinical Trials Historical Market (2017-2023)
9.3 North America Clinical Trials Market Forecast (2024-2032)
10 North America Clinical Trials Market by Service Type
10.1 Laboratory Service
10.1.1 Historical Trend (2017-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Bioanalytical Testing Services
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.2.3 Breakup by Type
10.2.3.1 Cell-Based Assays
10.2.3.2 Virology Testing
10.2.3.3 Serology, Immunogenicity, and Neutralizing Antibodies
10.2.3.4 PK/PD Testing
10.2.3.5 Method Development, Optimisation, and Validation
10.2.3.6 Biomarker Testing
10.2.3.7 Others
10.3 Decentralized Clinical Trial Services
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Patient Recruitment Services
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Site Identification Services
10.5.1 Historical Trend (2017-2023)
10.5.2 Forecast Trend (2024-2032)
10.6 Analytical Testing Services
10.6.1 Historical Trend (2017-2023)
10.6.2 Forecast Trend (2024-2032)
10.7 Supply and Logistics Services
10.7.1 Historical Trend (2017-2023)
10.7.2 Forecast Trend (2024-2032)
10.8 Protocol Designing Services
10.8.1 Historical Trend (2017-2023)
10.8.2 Forecast Trend (2024-2032)
10.9 Data Management Services
10.9.1 Historical Trend (2017-2023)
10.9.2 Forecast Trend (2024-2032)
10.10 Medical Device Testing Services
10.10.1 Historical Trend (2017-2023)
10.10.2 Forecast Trend (2024-2032)
10.11 Others
11 North America Clinical Trials Market by Phase
11.1 Phase I
11.1.1 Historical Trend (2017-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Phase II
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 Phase III
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 Phase IV
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
12 North America Clinical Trials Market by Therapeutic Area
12.1 Oncology
12.1.1 Historical Trend (2017-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Infectious Diseases
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Neurology
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Metabolic Disorders
12.4.1 Historical Trend (2017-2023)
12.4.2 Forecast Trend (2024-2032)
12.5 Immunology
12.5.1 Historical Trend (2017-2023)
12.5.2 Forecast Trend (2024-2032)
12.6 Cardiology
12.6.1 Historical Trend (2017-2023)
12.6.2 Forecast Trend (2024-2032)
12.7 Genetic Diseases
12.7.1 Historical Trend (2017-2023)
12.7.2 Forecast Trend (2024-2032)
12.8 Women’s Heath
12.8.1 Historical Trend (2017-2023)
12.8.2 Forecast Trend (2024-2032)
12.9 Others
13 North America Clinical Trials Market by Application
13.1 Small Molecules
13.1.1 Historical Trend (2017-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 Monoclonal Antibodies
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Vaccines
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 Cell and Gene Therapy
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 North America Clinical Trials Market by Country
14.1 United States of America
14.1.1 Historical Trend (2017-2023)
14.1.2 Forecast Trend (2024-2032)
14.2 Canada
14.2.1 Historical Trend (2017-2023)
14.2.2 Forecast Trend (2024-2032)
15 Market Dynamics
15.1 SWOT Analysis
15.1.1 Strengths
15.1.2 Weaknesses
15.1.3 Opportunities
15.1.4 Threats
15.2 Porter’s Five Forces Analysis
15.2.1 Supplier’s Power
15.2.2 Buyer’s Power
15.2.3 Threat of New Entrants
15.2.4 Degree of Rivalry
15.2.5 Threat of Substitutes
15.3 Key Indicators for Demand
15.4 Key Indicators for Price
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 IQVIA Inc
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Laboratory Corporation of America Holdings
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Syneos Health
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Charles River Laboratories.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Thermo Fisher Scientific Inc
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Parexel International (MA) Corporation.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Medpace, Inc.
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 ACM Global Laboratories
16.2.8.1 Company Overview
16.2.8.2 Product Portfolio
16.2.8.3 Demographic Reach and Achievements
16.2.8.4 Certifications
16.2.9 Frontage Labs
16.2.9.1 Company Overview
16.2.9.2 Product Portfolio
16.2.9.3 Demographic Reach and Achievements
16.2.9.4 Certifications
16.2.10 Dropoff, Inc.
16.2.10.1 Company Overview
16.2.10.2 Product Portfolio
16.2.10.3 Demographic Reach and Achievements
16.2.10.4 Certifications
16.2.11 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Clinical Trials Market: Key Industry Highlights, 2017 and 2032
2. North America Clinical Trials Market: Key Industry Highlights, 2017 and 2032
3. North America Clinical Trials Historical Market: Breakup by Service Type (USD Billion), 2017-2023
4. North America Clinical Trials Market Forecast: Breakup by Service Type (USD Billion), 2024-2032
5. North America Clinical Trials Historical Market: Breakup by Phase (USD Billion), 2017-2023
6. North America Clinical Trials Market Forecast: Breakup by Phase (USD Billion), 2024-2032
7. North America Clinical Trials Historical Market: Breakup by Therapeutic Area (USD Billion), 2017-2023
8. North America Clinical Trials Market Forecast: Breakup by Therapeutic Area (USD Billion), 2024-2032
9. North America Clinical Trials Historical Market: Breakup by Application (USD Billion), 2017-2023
10. North America Clinical Trials Market Forecast: Breakup by Application (USD Billion), 2024-2032
11. North America Clinical Trials Historical Market: Breakup by Country (USD Billion), 2017-2023
12. North America Clinical Trials Market Forecast: Breakup by Country (USD Billion), 2024-2032
13. North America Clinical Trials Market Structure
Key Questions Answered in the Report
In 2023, the clinical trials market reached an approximate value of USD 35.31 billion.
The market is expected to grow at a CAGR of 6.0% between 2024 and 2032.
The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach USD 60.16 billion by 2032.
Clinical trials are research studies that test a behavioural, medical, or surgical intervention in people. Through these trials, researchers determine if a new form of treatment, drug, diet, or medical device is safe for people.
FDA oversees clinical trials to ensure conducted, analysed, and reported as per federal law and good clinical practice (GCP) regulations. FDA also ensures that the right, safety, and welfare of the people participating in the trial is protected.
The major drivers of the market include a strong regulatory framework, the advancement of technology in the clinical trials market, and the rising number of people suffering from cancer and infectious diseases.
Key trends aiding market expansion include extensive research and development to advance the clinical trial market, the integration of technologies such as artificial intelligence, and the rising number of diseases.
Major countries in the market are the United States of America and Canada.
The common phases of clinical trials are phase I, phase II, phase III, and phase IV.
Key players in the market are IQVIA Inc., Laboratory Corporation of America Holdings, Syneos Health, Charles River Laboratories, Thermo Fisher Scientific Inc., Parexel International (MA) Corporation, Medpace, Inc., ACM Global Laboratories, Frontage Labs, Dropoff, Inc., and others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER